<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.beaconcancer.org/index.php?action=history&amp;feed=atom&amp;title=EGFR</id>
	<title>EGFR - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.beaconcancer.org/index.php?action=history&amp;feed=atom&amp;title=EGFR"/>
	<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=EGFR&amp;action=history"/>
	<updated>2026-10-17T03:42:14Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.39.5</generator>
	<entry>
		<id>https://wiki.beaconcancer.org/index.php?title=EGFR&amp;diff=22008&amp;oldid=prev</id>
		<title>Victor at 14:23, 27 August 2024</title>
		<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=EGFR&amp;diff=22008&amp;oldid=prev"/>
		<updated>2024-08-27T14:23:34Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 14:23, 27 August 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;EGFR, or Epidermal Growth Factor Receptor, is a protein found on the surface of cells that helps regulate cell growth, survival, and division. Mutations and overexpression of the EGFR gene are common in various cancers, particularly non-small cell lung cancer, glioblastoma, and head and neck cancers. These alterations lead to continuous activation of the EGFR protein, promoting uncontrolled cell proliferation and &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumor &lt;/del&gt;development. Identifying EGFR mutations in &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumors &lt;/del&gt;is crucial for determining the most effective treatment strategies, as targeted therapies, such as EGFR inhibitors, can specifically block this pathway and inhibit cancer growth. Understanding EGFR&amp;#039;s role in cancer allows for personalized treatment plans, improving patient outcomes through more precise and effective therapeutic interventions.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;EGFR, or Epidermal Growth Factor Receptor, is a protein found on the surface of cells that helps regulate cell growth, survival, and division. Mutations and overexpression of the EGFR gene are common in various cancers, particularly non-small cell lung cancer, glioblastoma, and head and neck cancers. These alterations lead to continuous activation of the EGFR protein, promoting uncontrolled cell proliferation and &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumour &lt;/ins&gt;development. Identifying EGFR mutations in &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumours &lt;/ins&gt;is crucial for determining the most effective treatment strategies, as targeted therapies, such as EGFR inhibitors, can specifically block this pathway and inhibit cancer growth. Understanding EGFR&amp;#039;s role in cancer allows for personalized treatment plans, improving patient outcomes through more precise and effective therapeutic interventions.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Victor</name></author>
	</entry>
	<entry>
		<id>https://wiki.beaconcancer.org/index.php?title=EGFR&amp;diff=18053&amp;oldid=prev</id>
		<title>Victor: Created page with &quot;EGFR, or Epidermal Growth Factor Receptor, is a protein found on the surface of cells that helps regulate cell growth, survival, and division. Mutations and overexpression of the EGFR gene are common in various cancers, particularly non-small cell lung cancer, glioblastoma, and head and neck cancers. These alterations lead to continuous activation of the EGFR protein, promoting uncontrolled cell proliferation and tumor development. Identifying EGFR mutations in tumors is...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=EGFR&amp;diff=18053&amp;oldid=prev"/>
		<updated>2024-05-21T18:05:42Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;EGFR, or Epidermal Growth Factor Receptor, is a protein found on the surface of cells that helps regulate cell growth, survival, and division. Mutations and overexpression of the EGFR gene are common in various cancers, particularly non-small cell lung cancer, glioblastoma, and head and neck cancers. These alterations lead to continuous activation of the EGFR protein, promoting uncontrolled cell proliferation and tumor development. Identifying EGFR mutations in tumors is...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;EGFR, or Epidermal Growth Factor Receptor, is a protein found on the surface of cells that helps regulate cell growth, survival, and division. Mutations and overexpression of the EGFR gene are common in various cancers, particularly non-small cell lung cancer, glioblastoma, and head and neck cancers. These alterations lead to continuous activation of the EGFR protein, promoting uncontrolled cell proliferation and tumor development. Identifying EGFR mutations in tumors is crucial for determining the most effective treatment strategies, as targeted therapies, such as EGFR inhibitors, can specifically block this pathway and inhibit cancer growth. Understanding EGFR&amp;#039;s role in cancer allows for personalized treatment plans, improving patient outcomes through more precise and effective therapeutic interventions.&lt;/div&gt;</summary>
		<author><name>Victor</name></author>
	</entry>
</feed>